Cresco Labs adds ex-Cboe chairman Edward Tilly to its board

September 17, 2026 6:30 AM EDT

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) has appointed Edward Tilly to its board of directors, effective September 18, 2026, according to a press release from the company.



Tilly will serve as an independent director and join the Audit Committee, bringing the total number of board members to eight. He has more than 35 years of experience in exchange operations, market structure, capital markets, and global regulatory engagement.



Tilly previously served as chairman and CEO of Cboe Global Markets for a decade, during which the company's market capitalization grew from approximately $2 billion to more than $18 billion. He led Cboe's $3.4 billion acquisition of BATS Global Markets and expanded operations to six continents. He also served as chairman of the World Federation of Exchanges from 2021 to 2023 and held board positions at the Options Clearing Corporation and the National Stock Exchange. Most recently, he served as CEO of Clear Street, a prime brokerage and financial infrastructure firm, and continues to serve on its board.



Tom Manning, Cresco Labs chairman of the board, commented on the appointment: "As the federal landscape evolves and U.S. capital markets access opens to companies like ours, few people better understand how to navigate the strategic and financial opportunities ahead."



Tilly said of joining the board: "Cresco has built a leading branded portfolio in U.S. cannabis and a retail platform that consistently outperforms its markets. That operating foundation positions the Company well as access to U.S. capital markets broadens."



Cresco Labs operates cannabis cultivation, production, and branded product distribution, along with retail dispensaries under the Sunnyside brand.


You May Also Be Interested In





Related Categories

Board Changes

Related Entities

Definitive Agreement